ScholarIQanswers from OpenAlex

The pharmacokinetics and safety of porfimer after repeated administration 30–45 days apart to patients undergoing photodynamic therapy

PaperCitations, authors & open-access status

The pharmacokinetics and safety of porfimer after repeated administration 30–45 days apart to patients undergoing photodynamic therapy is a paper indexed in ScholarIQ from OpenAlex.

How many citations does The pharmacokinetics and safety of porfimer after repeated administration 30–45 days apart to patients undergoing photodynamic therapy have?

ScholarIQcitation count

The pharmacokinetics and safety of porfimer after repeated administration 30–45 days apart to patients undergoing photodynamic therapy has 13 citations in the OpenAlex counts ScholarIQ stores.

When was The pharmacokinetics and safety of porfimer after repeated administration 30–45 days apart to patients undergoing photodynamic therapy published?

ScholarIQyear

The pharmacokinetics and safety of porfimer after repeated administration 30–45 days apart to patients undergoing photodynamic therapy has 2010 year in the ScholarIQ index.

What is the open-access status of The pharmacokinetics and safety of porfimer after repeated administration 30–45 days apart to patients undergoing photodynamic therapy?

ScholarIQoa status

The pharmacokinetics and safety of porfimer after repeated administration 30–45 days apart to patients undergoing photodynamic therapy has bronze oa status in the ScholarIQ index.

What is the DOI of The pharmacokinetics and safety of porfimer after repeated administration 30–45 days apart to patients undergoing photodynamic therapy?

ScholarIQdoi

The DOI for The pharmacokinetics and safety of porfimer after repeated administration 30–45 days apart to patients undergoing photodynamic therapy is on the source record.

What is the PMID of The pharmacokinetics and safety of porfimer after repeated administration 30–45 days apart to patients undergoing photodynamic therapy?

ScholarIQpmid

The PMID for The pharmacokinetics and safety of porfimer after repeated administration 30–45 days apart to patients undergoing photodynamic therapy is on the source record.

What is the OpenAlex record for The pharmacokinetics and safety of porfimer after repeated administration 30–45 days apart to patients undergoing photodynamic therapy?

ScholarIQopenalex

The OpenAlex for The pharmacokinetics and safety of porfimer after repeated administration 30–45 days apart to patients undergoing photodynamic therapy is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial